CDKAL1 gene variants (rs7756992 and rs10946398) and susceptibility to type 2 diabetes: Evidence from a Jordanian case-control study
Keywords:
CDKAL1, rs7756992, rs10946398, gene polymorphism, type 2 diabetes mellitus, genetic association, case-control study, jordan, susceptibility, risk factorsAbstract
Background: Type 2 diabetes (T2D) is a prevalent metabolic condition characterized by chronic hyperglycaemia due to impaired insulin secretion or sensitivity. The CDKAL1 gene is associated with T2D risk because of its role in insulin biosynthesis, with SNPs such as rs7756992 and rs10946398 exhibiting variable associations across different populations.
Objective: This study aims to assess the relationship between CDKAL1 variants rs7756992 and rs10946398 and the risk of T2D in the Jordanian population.
Method: We conducted a case-control study involving 200 participants (100 with T2D and 100 matched controls) from Prince Hamza Hospital. Genomic DNA was extracted and analyzed for rs7756992 and rs10946398 using real-time PCR (Allelic Discrimination Assay). Clinical and genetic data were evaluated using SPSS and SNPStats software.
Results: No significant association was found between rs7756992 and T2D or any clinical parameters. In contrast, significant differences in total cholesterol (TC) levels were identified between genotypes of rs10946398 within the T2D group (p=0.035) and in LDL cholesterol (LDL-C) levels within the control group (p=0.044). However, no significant association was observed between rs10946398 and T2D risk across all genetic models.
Conclusion: The study revealed a significant association between the CDKAL1 rs10946398 variant and TC levels in T2D patients, indicating a potential gene-environment interaction. No overall significant associations with T2D risk were observed for either SNP. Further research with larger sample sizes is required to validate these findings in the Jordanian population.
References
1. Xu N, Zhang TT, Han WJ, et al. Association of CDKAL1 RS10946398 Gene Polymorphism with Susceptibility to Diabetes Mellitus Type 2: A Meta-Analysis. J Diabetes Res. 2021;2021:1254968.doi: 10.1155/2021/1254968
2. Goyal Y, Verma AK, Joshi PC, Dev K. Contemplating the role of genetic variants of HHEX, CDKAL1, WFS1 and SLC30A8 genes of TYPE-2 diabetes in Asians ethnic groups. Gene Reports. 2019;17.doi: 10.1016/j.genrep.2019.100465
3. Awad SF, Huangfu P, Dargham SR, et al. Characterizing the type 2 diabetes mellitus epidemic in Jordan up to 2050. Sci Rep. 2020;10(1):21001.doi: 10.1038/s41598-020-77970-7
4. Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020;21(17).doi: 10.3390/ijms21176275
5. Verma AK, Goyal Y, Bhatt D, et al. Association Between CDKAL1, HHEX, CDKN2A/2B and IGF2BP2 Gene Polymorphisms and Susceptibility to Type 2 Diabetes in Uttarakhand, India. Diabetes Metab Syndr Obes. 2021;14:23-36.doi: 10.2147/DMSO.S284998
6. Witka BZ, Oktaviani DJ, Marcellino M, Barliana MI, Abdulah R. Type 2 Diabetes-Associated Genetic Polymorphisms as Potential Disease Predictors. Diabetes Metab Syndr Obes. 2019;12:2689-706.doi: 10.2147/DMSO.S230061
7. Suzuki K, Hatzikotoulas K, Southam L, et al. Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications. medRxiv. 2023.doi: 10.1101/2023.03.31.23287839
8. Li YY, Wang LS, Lu XZ, et al. CDKAL1 gene rs7756992 A/G polymorphism and type 2 diabetes mellitus: a meta-analysis of 62,567 subjects. Sci Rep. 2013;3:3131.doi: 10.1038/srep03131
9. Quaranta M, Burden AD, Griffiths CE, et al. Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetes. Genes Immun. 2009;10(7):654-8.doi: 10.1038/gene.2009.51
10. Palmer CJ, Bruckner RJ, Paulo JA, et al. Cdkal1, a type 2 diabetes susceptibility gene, regulates mitochondrial function in adipose tissue. Mol Metab. 2017;6(10):1212-25.doi: 10.1016/j.molmet.2017.07.013
11. Ghosh C, Das N, Saha S, et al. Involvement of Cdkal1 in the etiology of type 2 diabetes mellitus and microvascular diabetic complications: a review. J Diabetes Metab Disord. 2022;21(1):991-1001.doi: 10.1007/s40200-021-00953-6
12. Li C, Shen K, Yang M, et al. Association Between Single Nucleotide Polymorphisms in CDKAL1 and HHEX and Type 2 Diabetes in Chinese Population. Diabetes Metab Syndr Obes. 2020;13:5113-23.doi: 10.2147/DMSO.S288587
13. Arroyo MN, Green JA, Cnop M, Igoillo-Esteve M. tRNA Biology in the Pathogenesis of Diabetes: Role of Genetic and Environmental Factors. International Journal of Molecular Sciences [Internet]. 2021; 22(2).
14. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007;39(6):770-5.doi: 10.1038/ng2043
15. Horikawa Y, Miyake K, Yasuda K, et al. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab. 2008;93(8):3136-41.doi: 10.1210/jc.2008-0452
16. Liu Y, Yu L, Zhang D, et al. Positive association between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals. Diabetologia. 2008;51(11):2134-7.doi: 10.1007/s00125-008-1141-6
17. Omori S, Tanaka Y, Takahashi A, et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes. 2008;57(3):791-5.doi: 10.2337/db07-0979
18. Li-Gao R, Wakil SM, Meyer BF, Dzimiri N, Mook-Kanamori DO. Replication of Type 2 diabetes-associated variants in a Saudi Arabian population. Physiol Genomics. 2018;50(4):296-7.doi: 10.1152/physiolgenomics.00100.2017
19. Herder C, Rathmann W, Strassburger K, et al. Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies. Horm Metab Res. 2008;40(10):722-6.doi: 10.1055/s-2008-1078730
20. Chauhan G, Spurgeon CJ, Tabassum R, et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians. Diabetes. 2010;59(8):2068-74.doi: 10.2337/db09-1386
21. DeMenna J, Puppala S, Chittoor G, et al. Association of common genetic variants with diabetes and metabolic syndrome related traits in the Arizona Insulin Resistance registry: a focus on Mexican American families in the Southwest. Hum Hered. 2014;78(1):47-58.doi: 10.1159/000363411
22. Ambiger S, Farheen F, Jaalam K, Shivalingappa J. Correlation of LDL Cholesterol Calculated by Friedewald’s, Puavilai’s, Vujovic’s, de Cordova’s and Martin’s Formulae with Directly Measured LDL Cholesterol: A Cross-sectional Study. Journal of Clinical and Diagnostic Research. 2023;17(7):BC10-BC5.doi: 10.7860/JCDR/2023/60981.18231
23. Radcliffe Department of Medicine. HOMA Calculator 2017 [Available from: https://www.rdm.ox.ac.uk/about/our-clinical-facilities-and-mrc-units/DTU/software/homa.
24. Berman JJ. Chapter 4 - Understanding Your Data. In: Berman JJ, editor. Data Simplification. Boston: Morgan Kaufmann; 2016. p. 135-87.doi: 10.1016/B978-0-12-803781-2.00004-7
25. Tremblay J, Hamet P. Environmental and genetic contributions to diabetes. Metabolism. 2019;100S:153952.doi: 10.1016/j.metabol.2019.153952
26. Ma CX, Ma XN, Guan CH, et al. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022;21(1):74.doi: 10.1186/s12933-022-01516-6
27. Singh A, Kukreti R, Saso L, Kukreti S. Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes. Molecules [Internet]. 2022; 27(3).
28. Alkhalidy H, Orabi A, Alnaser K, et al. Obesity Measures as Predictors of Type 2 Diabetes and Cardiovascular Diseases among the Jordanian Population: A Cross-Sectional Study. Int J Environ Res Public Health. 2021;18(22):12187.doi: 10.3390/ijerph182212187
29. Bazyar H, Zare Javid A, Masoudi MR, et al. Assessing the predictive value of insulin resistance indices for metabolic syndrome risk in type 2 diabetes mellitus patients. Sci Rep. 2024;14(1):8917.doi: 10.1038/s41598-024-59659-3
30. Pavlou DI, Paschou SA, Anagnostis P, et al. Hypertension in patients with type 2 diabetes mellitus: Targets and management. Maturitas. 2018;112:71-7.doi: 10.1016/j.maturitas.2018.03.013
31. Liu Y, Li J, Dou Y, Ma H. Impacts of type 2 diabetes mellitus and hypertension on the incidence of cardiovascular diseases and stroke in China real-world setting: a retrospective cohort study. BMJ Open. 2021;11(11):e053698.doi: 10.1136/bmjopen-2021-053698
32. Alfaifi M. Contribution of genetic variant identified in HHEX gene in the overweight Saudi patients confirmed with type 2 diabetes mellitus. Saudi J Biol Sci. 2022;29(2):804-8.doi: 10.1016/j.sjbs.2021.10.028
33. Boye KS, Thieu VT, Lage MJ, Miller H, Paczkowski R. The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study. Adv Ther. 2022;39(5):2208-21.doi: 10.1007/s12325-022-02106-4
34. He L, Zheng W, Li Z, Kong W, Zeng T. Association of four lipid-derived indicators with the risk of developing type 2 diabetes: a Chinese population-based cohort study. Lipids Health Dis. 2023;22(1):24.doi: 10.1186/s12944-023-01790-7
35. Park SS, Seo YK. Excess Accumulation of Lipid Impairs Insulin Sensitivity in Skeletal Muscle. Int J Mol Sci. 2020;21(6).doi: 10.3390/ijms21061949
36. Wysham C, Shubrook J. Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications. Postgrad Med. 2020;132(8):676-86.doi: 10.1080/00325481.2020.1771047
37. Kahn SE, Chen YC, Esser N, et al. The beta Cell in Diabetes: Integrating Biomarkers With Functional Measures. Endocr Rev. 2021;42(5):528-83.doi: 10.1210/endrev/bnab021
38. Benberin VV, Vochshenkova TA, Abildinova GZ, Borovikova AV, Nagimtayeva AA. Polymorphic genetic markers and how they are associated with clinical and metabolic indicators of type 2 diabetes mellitus in the Kazakh population. J Diabetes Metab Disord. 2021;20(1):131-40.doi: 10.1007/s40200-020-00720-z
39. Okamura T, Yanobu-Takanashi R, Takeuchi F, et al. Deletion of CDKAL1 affects high-fat diet-induced fat accumulation and glucose-stimulated insulin secretion in mice, indicating relevance to diabetes. PLoS One. 2012;7(11):e49055.doi: 10.1371/journal.pone.0049055
40. Hertel JK, Johansson S, Raeder H, et al. Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study). Diabetologia. 2008;51(6):971-7.doi: 10.1007/s00125-008-0982-3
41. Benrahma H, Charoute H, Lasram K, et al. Association analysis of IGF2BP2, KCNJ11, and CDKAL1 polymorphisms with type 2 diabetes mellitus in a Moroccan population: a case-control study and meta-analysis. Biochem Genet. 2014;52(9-10):430-42.doi: 10.1007/s10528-014-9658-5
42. Darwish R, Abdel-Hamid E, Gohar N, Soliman A, Naguib M. Single Nucleotide Polymorphisms in CDKAL1 Gene are Not Associated with Risk of Type 2 Diabetes Mellitus in a Group of Egyptian Population. Biomedical and Pharmacology Journal. 2020;13(02):529-35.doi: 10.13005/bpj/1914
43. Liang Y, Shu Y, Luo H, Chen R, Zeng Z. Correlation between CDKAL1 rs10946398C>A single nucleotide polymorphism and type 2 diabetes mellitus susceptibility: A meta-analysis. Open Life Sciences. 2017;12(1):501-9.doi: 10.1515/biol-2017-0059
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Manar Atoum, Ala' Almehsen
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
